Ausgabe 1/2012
Inhalt (12 Artikel)
Editorial
Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe?
Michael Drummond, Adrian Towse
Original Paper
The convergence of health care financing structures: empirical evidence from OECD-countries
Andrea M. Leiter, Engelbert Theurl
Original Paper
Decomposing the determinants of health care expenditure: the case of Spain
David Cantarero Prieto, Santiago Lago-Peñas
Original Paper
The impact of presumed consent laws and institutions on deceased organ donation
Fırat Bilgel
Open Access
Original Paper
Spillover effects of supplementary on basic health insurance: evidence from the Netherlands
Anne-Fleur Roos, Frederik T. Schut
Open Access
Original paper
Future costs in cost-effectiveness analysis: an empirical assessment
Marie Kruse, Jan Sørensen, Dorte Gyrd-Hansen
Original Paper
Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy
O. Zaniolo, S. Iannazzo, L. Pradelli, M. Miravitlles
Open Access
Original Paper
The cost of multiple sclerosis in Norway
B. Svendsen, K.-M. Myhr, H. Nyland, J. H. Aarseth
Open Access
Original Paper
Do smoke-free laws affect revenues in pubs and restaurants?
Hans Olav Melberg, Karl E. Lund
Original Paper
Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands
I. Lenoir-Wijnkoop, W. M. C. van Aalderen, G. Boehm, D. Klaassen, A. B. Sprikkelman, M. J. C. Nuijten
Original Paper
Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications
Nick Kontodimopoulos, Evelina Pappa, Zinovia Chadjiapostolou, Eleni Arvanitaki, Angelos A. Papadopoulos, Dimitris Niakas